We’ve got collated a listing of suggestions from high world brokerage corporations from ETNow:
CLSA on UltraTech Cement and Dalmia Bharat:
CLSA maintained outperform score on UltraTech Cement and Dalmia Bharat with a goal value of Rs 7365 and Rs 1705, respectively.
The demand outlook continues to stay sturdy within the medium time period. The sector is heading into seasonal weak point, and profitability is more likely to backside out in Q2.
CLSA on Eicher Motors: Purchase| Goal Rs 4154
CLSA maintained a purchase score on Eicher Motors with a goal value of Rs 4154. The inventory closed at Rs 3363 on 22 August.
The corporate is seeing a robust alternative demand which is more likely to assist Royal Enfield’s quantity progress, CLSA stated.
“Exports are more likely to be a key progress space. Royal Enfield’s EBITDA per automobile is poised to climb greater,” stated the observe.
Goldman Sachs on Gland Pharma: Purchase| Goal Rs 2830
Goldman Sachs initiated a purchase score on Gland Pharma with a goal value of Rs 2830. The inventory closed at Rs 2370 on 22 August.
Gland Pharma is a number one world participant. The worldwide funding financial institution expects a rebound in FY24E, with a 27% topline progress.
EBITDA margins to stay largely steady between FY22 and FY24E, stated the observe.
(Disclaimer: Suggestions, options, views and opinions given by the specialists are their very own. These don’t signify the views of Financial Instances)
